NanoString Skip Navigation

NanoString Technologies

1.888.358.6266

Site Navigation

  1. Applications Overview
    1. Applications Overview
    2. Technology
    3. Gene Expression Analysis
    4. miRNA Expression Analysis
    5. miRGE Analysis
    6. Copy Number Variation
    7. Leukemia Fusion Gene
    8. Publications
  2. Products Overview
    1. Products Overview
    2. nCounter Instrumentation
    3. nSolver Analysis Software
    4. nCounter Gene Expression
    5. nCounter miRNA Expression
    6. nCounter miRGE CodeSets
    7. nCounter CNV CodeSet
    8. nCounter Leukemia Fusion
    9. nCounter Workflow
    10. Ordering Information
    11. Webinars and Videos
    12. Contact Sales
  3. Support Overview
    1. Support Overview
    2. FAQs
    3. Product Literature
    4. nCounter Software
    5. Contact Support
  4. Community Overview
    1. Community Overview
    2. Core & Service Lab Listings
    3. Upcoming Events
    4. Mail List
    5. Join nCounter Community
  5. Corporate Overview
    1. Corporate Overview
    2. Management Team
    3. Media Center
    4. Locations
    5. Contact Us
    6. Careers
    7. Legal

Site Tools


You are here:

  1. Home
  2. Corporate
  3. Media Center

Sectional Navigation

Need Help?

Telephone Operator

Contact us for support either by phone or online.

1 888 358 6266
Contact Us

Join our mailing list

Get news from us on software releases, new innovations and upcoming events!

Sign Up

Welcome to the NanoString Media Center, where you will find press releases, news articles about NanoString Technologies and our Image Library. Download our Corporate Fact Sheet.

Recent Media Coverage

Dec. 8
2011 		NanoString Nails Breast Cancer Study, Challenging Genomic Health
Nov. 7
2011 		NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics
Nov. 7
2011 		GE Among Investors in NanoString's $20M Financing Round

Recent Press Releases

Dec. 8
2011 		NanoString Technologies Announces Positive Results from First Validation Study of PAM50-based Breast Cancer Assay
Nov. 7
2011 		NanoString Secures $20M in Series D Financing
Oct. 12
2011 		NanoString Announces Launch of Second Generation nCounter Analysis System
Sep. 21
2011 		NanoString Introduces Solution for Simultaneously Measuring miRNA and mRNA Expression Levels
Aug. 5
2011 		NanoString Introduces Rat miRNA Expression Assays
Aug. 3
2011 		NanoString Embarks on First in Series of Clinical Studies for Breast Cancer Intrinsic Subtyping Assay
Jul. 28
2011 		NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
Jun. 3
2011 		Data Supporting Utility of the PAM50 Assay for Breast Cancer Gene Expression Profiling to be Presented at ASCO
Feb. 22
2011 		NanoString Technologies Introduces Multiplexed Assay Kit for Human Molecular Karyotyping
Feb. 1
2011 		NanoString Technologies Names J. Wayne Cowens, M.D. Chief Medical Officer

Related Links